NO20006320L - Cykliske somatostatin-analoger - Google Patents

Cykliske somatostatin-analoger

Info

Publication number
NO20006320L
NO20006320L NO20006320A NO20006320A NO20006320L NO 20006320 L NO20006320 L NO 20006320L NO 20006320 A NO20006320 A NO 20006320A NO 20006320 A NO20006320 A NO 20006320A NO 20006320 L NO20006320 L NO 20006320L
Authority
NO
Norway
Prior art keywords
present
somatostatin analogues
relates
cyclic somatostatin
somatostatin
Prior art date
Application number
NO20006320A
Other languages
English (en)
Other versions
NO20006320D0 (no
Inventor
Thomas D Gordon
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of NO20006320D0 publication Critical patent/NO20006320D0/no
Publication of NO20006320L publication Critical patent/NO20006320L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Foreliggende oppfinnelse angår cykliske derivater inneholdende en imidazol cis- amidbindingsetterlikning som binder selektivt til somatostatin reseptorundertyper og anvendelsen derav ved behandling av tilstander som kan behandles ved å frembringe en agonist- eller antagonist-effekt fra somatostatin-undertype-reseptorene. Foreliggende oppfinnelse angår også fremgangsmåter for fremstilling av forbindelsene ifølge foreliggende oppfinnelse.
NO20006320A 1998-06-16 2000-12-12 Cykliske somatostatin-analoger NO20006320L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9818198A 1998-06-16 1998-06-16
US8950398P 1998-06-16 1998-06-16
PCT/US1999/013304 WO1999065942A1 (en) 1998-06-16 1999-06-11 Cyclic somatostatin analogs

Publications (2)

Publication Number Publication Date
NO20006320D0 NO20006320D0 (no) 2000-12-12
NO20006320L true NO20006320L (no) 2001-02-12

Family

ID=26780645

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006320A NO20006320L (no) 1998-06-16 2000-12-12 Cykliske somatostatin-analoger

Country Status (12)

Country Link
EP (1) EP1086131A1 (no)
JP (1) JP2002518409A (no)
CN (1) CN1200000C (no)
AR (1) AR021161A1 (no)
AU (1) AU745493B2 (no)
CA (1) CA2335184A1 (no)
HU (1) HUP0102902A3 (no)
NO (1) NO20006320L (no)
PL (1) PL345037A1 (no)
RU (1) RU2242481C2 (no)
TW (3) TW527361B (no)
WO (1) WO1999065942A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0202648A3 (en) 1998-06-12 2003-02-28 Sod Conseils Rech Applic Imidazolyl derivatives, pharmaceutical compositions containing them and their use
FR2796945B1 (fr) 1999-07-30 2002-06-28 Sod Conseils Rech Applic Nouveaux derives d'hydantoines, de thiohydantoines, de pyrimidinediones et de thioxopyrimidinones, leurs procedes de preparation et leur application a titre de medicaments
US7566734B2 (en) * 2000-08-01 2009-07-28 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Imidazolyl derivatives
US20040186151A1 (en) * 2003-02-12 2004-09-23 Mjalli Adnan M.M. Substituted azole derivatives as therapeutic agents
US8017575B2 (en) 2004-12-15 2011-09-13 Wilfred Wayne Lautt Treatment of insulin resistance by modulating somatostatin using somatostatin receptor antagonists
JP5225098B2 (ja) 2005-12-14 2013-07-03 ブリストル−マイヤーズ スクイブ カンパニー 第ＸＩａ因子インヒビターとしてのアリールプロピオンアミド、アリールアクリルアミド、アリールプロピンアミド、またはアリールメチルウレアアナログ
ES2365815T3 (es) * 2005-12-14 2011-10-11 Bristol-Myers Squibb Company Análogos de arilpropionamida, arilacrilamida, arilpropinamida o arilmetilurea como inhibidores del factor xia.
PE20110480A1 (es) 2008-09-26 2011-07-01 Ambrx Inc Microorganismos y vacunas dependientes de replicacion de aminoacidos no naturales
EP2168983A1 (fr) * 2008-09-30 2010-03-31 Ipsen Pharma Nouveaux composés octapeptidiques et leur utilisation thérapeutique
JP5535931B2 (ja) * 2008-10-27 2014-07-02 武田薬品工業株式会社 二環性化合物
AU2017217271C1 (en) * 2016-02-09 2021-08-05 Cdrd Ventures Inc. Somatostatin receptor antagonist compounds and methods of using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770687A (en) * 1995-06-07 1998-06-23 Peptor Limited Comformationally constrained backbone cyclized somatostatin analogs
GB9513224D0 (en) * 1995-06-29 1995-09-06 Sandoz Ltd Organic compounds
US6673927B2 (en) * 1996-02-16 2004-01-06 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Farnesyl transferase inhibitors

Also Published As

Publication number Publication date
CN1305496A (zh) 2001-07-25
TWI242441B (en) 2005-11-01
HUP0102902A3 (en) 2002-02-28
JP2002518409A (ja) 2002-06-25
HUP0102902A2 (hu) 2002-01-28
TW200410986A (en) 2004-07-01
CA2335184A1 (en) 1999-12-23
AR021161A1 (es) 2002-07-03
TW527361B (en) 2003-04-11
CN1200000C (zh) 2005-05-04
PL345037A1 (en) 2001-11-19
AU4822399A (en) 2000-01-05
WO1999065942A8 (en) 2000-02-17
WO1999065942A1 (en) 1999-12-23
NO20006320D0 (no) 2000-12-12
RU2242481C2 (ru) 2004-12-20
EP1086131A1 (en) 2001-03-28
TWI242442B (en) 2005-11-01
AU745493B2 (en) 2002-03-21

Similar Documents

Publication Publication Date Title
DE602005021494D1 (de) Substituierte pyrazole, derartige verbindungen enthaltende zusammensetzungen und verfahren zu ihrer verwendung
DE69835225D1 (de) Methode zur behandlung von durch glycocorticoidstörungen verursachten psychosen
TW200745031A (en) Acyl indoles, compositions containing such compounds and methods of use
YU34898A (sh) Antagonisti ccr-3 receptora
AUPO755097A0 (en) Receptor agonist and antagonist
WO2004100875A3 (en) Benzimidazoles, compositions containing such compounds and methods of use
WO2004069158A3 (en) Substituted pyrazoles, compositions containing such compounds and methods of use
WO1999010338A3 (en) Benzylidene- and cinnamylidene-anabaseines as neuronal nicotinic alpha-7 receptor agonists
BRPI0414087A (pt) composto, métodos para tratar um distúrbio, para demostrar a presença de receptores de crf em amostras de célula ou tecido, e para inibir a ligação de crf a um receptor de crf1, composição farmacêutica, e, embalagem
ATE144773T1 (de) Indol-derivate als 5-ht1-ähnliche antagonisten zur behandlung von migräne
ATE171447T1 (de) Benzimidazole derivate
DE60312474D1 (de) 5-ht3-rezeptorantagonisten und verwendungsverfahren
WO1999065942A8 (en) Cyclic somatostatin analogs
DK1061803T3 (da) Eprosartansammensætninger
ATE429421T1 (de) Arylindenopyridin- und arylindenopyrimidinverbindungen und ihre verwendung als adenosin-a2a-rezeptor antagonisten
PL364358A1 (en) Receptor in the edb fibronectin domain (ii)
MX2007004661A (es) Derivados de 1-(hetero)aril-3-amino-pirrolidina para usarse como antagonistas del receptor mglur3.
MXPA05013256A (es) Derivados de 1-(alquilaminoalquil-pirolidin-/piperidinil) -2,2-difenilacetamida como antagonistas de receptores muscarinicos.
AU2251801A (en) Piperidine derivatives and their use as serotonin receptor antagonists
DE69803883D1 (de) Neue verbindungen, welche antagonisten sind für p2-purinorezeptor 7-transmembran (tm) g-protein gekoppelte rezeptoren
WO2007001466A3 (en) Peptidomimetic somatostatin receptor subtype 2 ligands and pet imaging agents
EA200300850A1 (ru) Применение антагонистов рецептора gal3 при лечении депрессии и/или тревоги и соединения, полезные в таких способах
DE60135773D1 (en) Assays
DE602005019090D1 (de) Pyrrolidin-2-on-Derivate zur Verwendung als DP1-Rezeptoragonisten
BRPI0408979A (pt) uso de um antagonista e receptor de tipo 1 da angiotensina ii sozinho ou em combinação com uma substáncia anti-hipertensiva metabolicamente neutra, e, método para o tratamento e/ou prevenção de sìndrome metabólica

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application